The Pro-Life Feminist

Legislative Advocacy

May26, 2026 (vol 14)

Pro-life Feminists! 


Please take a read, and reach out to the NYS Legislators denoted. Our voice matters.


Thank you in advance, on behalf of children, born and pre-born, mothers, fathers and families in NY.


Pending Bills WORTH OUR TIME AND ATTENTION

If you are a registered NY voter, please contact the NY Legislators below. When you reach out, please include the BLUE bill numbers for the bills you reference and request either a YES or NO vote.

 

1. Adoption Support Timeline Expansion


As of May 2026, companion bills S5737-A/A2425-A have passed the Assembly, were amended in the Senate, and are currently pending before the Senate Committee on Children and Families.


FCLNY urges you to reach out to the members of the Children and Families Committee of the NY Senate and ask them to VOTE YES to this bill. 


This bill expands practical, necessary support for vulnerable expectant mothers during pregnancy while strengthening adoption as a stable and life-affirming option for both mother and child.


Under NY law (Social Services Law §374(6)), adoptive parents may pay reasonable and actual pregnancy-related expenses for a birth mother, including housing, maternity clothing, clothing for the child, transportation, medical and hospital costs related to pregnancy and birth, and legal fees connected to the adoption. S5737-A/A2425-A extend the period during which adoptive parents may assist with such pregnancy-related expenses, to 180 days before birth (instead of 60), and 45 days after birth (instead of 30). This recognizes a straightforward reality: financial pressures often intensify long before birth and can heavily influence whether vulnerable women feel they have real choices.


By allowing adoptive families to assist with reasonable and actual pregnancy-related expenses for a longer period, this proposed law helps stabilize expectant mothers earlier in pregnancy, reduces economic pressure, and strengthens adoption as a realistic option for women who may otherwise feel they have few alternatives.


Adoption affirms both the dignity of the child and the well-being of the mother, and expanding lawful assistance promotes stability, informed decision-making, and healthier outcomes that benefit families and society alike. Importantly, this support should be understood as advancing ethical adoption practices that protect women and children, and not as an endorsement of surrogacy arrangements, which raise separate and serious concerns about the commercialization and potential exploitation of women’s bodies.


NOTE: Research consistently shows that abortion in the United States is disproportionately concentrated among economically vulnerable women, many of whom are low-income and facing significant financial stress during unplanned pregnancies. NY’s Medicaid-funded abortion framework likewise reflects the reality that many women confronting unintended pregnancies are experiencing economic hardship. These women are, in practical terms, also potential birth mothers, and public policy should ensure that financial hardship does not limit life-affirming choices.

NY SENATE

Children and Families Committee Members

2. Abortion Pill Deregulation


A1172-A/S2533-A are both currently lodged within the Higher Education Committees in their respective chambers, with neither bill having yet passed the NY Senate or Assembly.


FCLNY urges you to reach out to the members of the Higher Education Committee in the NY Senate and NY Assembly and ask them to VOTE NO to this bill. 


This bill would dramatically expand abortion-pill distribution through blanket standing orders that bypass traditional patient-specific prescribing, weakening individualized medical oversight, accountability, and safeguards for women’s health and safety


A1172-A/S2533-A would significantly expand access to abortion pills in NY by authorizing non-patient-specific standing orders that allow pharmacists and nurses to dispense abortion drugs without an individual patient-specific prescription issued directly by a physician or other prescriber. While NY already permits abortion-pill prescribing through telehealth, these bills go further by replacing traditional patient-specific prescribing with standing-order distribution protocols that rely heavily on patient self-reporting and standardized screening procedures. The legislation would also require insurance coverage for abortion drugs without cost-sharing, further embedding abortion-pill access into NY’s healthcare system.


This bill strips away key medical safeguards, by reducing direct oversight and individualized clinical review, normalizing abortion as routine pharmacy care and expanding abortion access at the expense of protections for women, girls and their unborn children.

NY ASSEMBLY

Higher Education Committee Members

NY SENATE

Higher Education Committee Members

3. Abortion Pill Prescriber and Dispenser Anonymity


S8656-A has passed the NY Senate, been delivered to the Assembly, and is currently under consideration in the Assembly Higher Education Committee as companion bill A10428. 


FCLNY urges you to reach out to the members of the Higher Education Committee of the NY Assembly and ask them to VOTE NO to this bill.


This bill allows abortion-pill prescriptions to be dispensed without key identifying information on the label, weakening transparency, accountability, and basic medical safeguards in the distribution of drugs associated with potentially serious complications.


Bill S8656-A/A10428 allows abortion-pill prescriptions in NY to be dispensed without public identifying information, including the name and address of the abortion pill prescriber or dispenser (including pharmacies) appearing on prescription labels, further expanding NY’s abortion shield protections. While protecting patient privacy is important and already supported under existing law, this bill goes further by removing prescriber and dispenser identification, reducing transparency and accountability in the distribution of abortion drugs. Eliminating this crucial identifying information weakens basic medical safeguards, makes oversight and follow-up care more difficult, and prioritizes anonymous abortion access over clear medical accountability and protections for pregnant mothers and their children in utero. 

See above for the NY ASSEMBLY HIGHER EDUCATION COMMITTEE MEMBERS

4. State-Funded Abortion Expansion


S1438-A has passed in the NY Senate, been delivered to the Assembly, and is currently under consideration in the Assembly Health Committee.  *The Assembly is considering the same Senate bill directly. 


FCLNY urges you to reach out to the members of the Health Committee of the NY Assembly and ask them to VOTE NO to this bill. 


S1438-A uses taxpayer funds to expand abortion infrastructure statewide while failing to require critical abortion complication tracking, safety oversight, or comparable investment in life-affirming support services for women facing difficult pregnancies.


Bill S1438-A would establish a state-funded clinical training program intended to expand abortion service capacity in NY, including by increasing the number of trained abortion providers statewide. While framed as a clinical training initiative, the practical effect of the bill is the long-term expansion of abortion services, including both procedural and medication abortion. Notably, S1438A does not require any corresponding training in the identification, tracking, or reporting of abortion complications, including those associated with abortion pills, leaving significant gaps in safety oversight and public transparency within the program. The proposal likewise provides no comparable investment in life-affirming alternatives or maternal support services that assist women facing difficult pregnancies. Sound public policy should prioritize women’s safety, accountability, and balanced healthcare support rather than directing state resources toward expanding abortion capacity. At a time when lawmakers are asked to expand abortion policy, NY still lacks the basic complication data needed to ensure informed, evidence-based decision-making.


NOTE: Despite the seriousness of abortion as a medical intervention, NY has no law or regulation requiring the Department of Health, or any other state agency, to specifically track or publicly report abortion complications, leaving the state without a clear, transparent system to monitor outcomes or ensure accountability. NY law also does not require the state to report abortion data to the Centers for Disease Control and Prevention (CDC). As a result, any complications are only incidentally captured, if at all, through broad hospital and adverse-event reporting systems that were never designed to provide abortion-specific oversight.

NYS ASSEMBLY

Health Committee Members

Feminists Choosing Life of New York


1545 East Avenue, Suite 1, Rochester, NY 14610

(585)730-7808

info@fclny.org

www.fclny.org


Stay connected with us!

X Share This Email
LinkedIn Share This Email
Facebook  Instagram  TikTok  Twitter  YouTube